The Benefits Dilemma: Taming Costs While Keeping Talent in the GLP-1 Era
- 64% of companies report significant budget strain due to rising benefit costs (Espresa, 2026).
- GLP-1 drug costs have doubled in a year, now accounting for 10.5% of all prescription drug claims (Espresa, 2026).
- 95% of organizations saw improved employee retention after implementing flexible benefits (Espresa, 2026).
Experts agree that the rising cost of employee benefits, particularly for specialty drugs like GLP-1s, is forcing companies to innovate by shifting toward flexible, personalized benefits to balance fiscal responsibility and talent retention.
The Benefits Dilemma: Taming Costs While Keeping Talent in the GLP-1 Era
PALO ALTO, CA – June 10, 2026 – A quiet crisis is unfolding in corporate finance and human resources departments across the globe. It’s not a supply chain disruption or a new competitive threat, but the inexorable rise of a single line item: employee benefits. What was once a manageable expense has ballooned into the number one concern for employers, creating a high-stakes tightrope walk between fiscal responsibility and the critical need to retain top talent.
A new benchmark report from personal benefits platform Espresa, analyzing over half a million employee claims, puts a fine point on this reality. The report reveals that rising benefit costs, which ranked a distant sixth among employer concerns in 2021, now sit at the top of the list, with 64% of companies reporting significant budget strain. This isn't just a statistical shift; it's a strategic realignment forced by a new economic reality, one where the old playbook for employee compensation is no longer viable.
The Unrelenting Squeeze of Healthcare Costs
The pressure on employers is not an isolated finding. Data from across the benefits industry paints a stark picture of escalating costs that are rapidly becoming unsustainable. Consulting firm Aon forecasts that average U.S. employer health costs will surge past $17,000 per employee in 2026, following several years of aggressive increases. Similarly, WTW (Willis Towers Watson) found that 90% of employers now identify rising benefit costs as their primary strategic challenge, a dramatic jump from just a few years ago.
This financial strain is not confined to the C-suite; it’s being acutely felt by employees. The Espresa report notes that in the past year, a staggering 59% of employees delayed medical care due to cost, while 45% feel financially stretched by healthcare expenses. This corroborates findings from the Kaiser Family Foundation, which reported the average annual premium for family coverage has climbed to nearly $27,000, with employees contributing almost $7,000 out of pocket. The signal is clear: the current model is failing both sides. As companies pass on more costs through higher deductibles and premiums, they risk eroding employee loyalty and well-being, the very assets they need to compete.
The GLP-1 Effect: A Catalyst for Change
Pouring fuel on this fire is the explosive growth of specialty drugs, most notably the class of GLP-1 medications used for diabetes and weight loss. These drugs, while offering significant health benefits, have introduced a new level of cost volatility that has left benefits managers reeling.
According to Espresa's data, employer spending on GLP-1s has doubled in a single year, from $11 to $24 per member per month. These drugs now account for 10.5% of all prescription drug claims, up from just 6.9% in 2023. This is not a statistical anomaly; independent research from the International Foundation of Employee Benefit Plans confirms this exact figure. The dilemma for employers is profound. With one in four employees stating that access to GLP-1s directly impacts their perception of an employer's benefits package, the pressure to provide coverage is immense. Yet the cost, which can run upwards of $1,200 per month per employee, is a direct threat to the bottom line.
“Rising benefit costs, especially for specialty drugs like GLP-1s, place a massive strain between HR teams who want to retain top talent and finance teams focused on the bottom line,” said Alex Shubat, co-founder and CEO of Espresa, in the report's announcement. This tension is forcing companies to look for a third way—a strategy that moves beyond the binary choice of either absorbing crippling costs or cutting crucial benefits.
The Strategic Pivot: Rebalance, Don't Retreat
The most telling signal in the current landscape is not the crisis itself, but the strategic response it is generating. Rather than a widespread retreat from benefits, a majority of companies are choosing to innovate. The Espresa report finds that 57% of employers plan to rebalance and reallocate their existing benefits budgets over the next three years. The intent is not to spend less, but to spend smarter.
“The answer isn't to cut benefits, as we've seen many companies do, it's to make every dollar work harder by giving employees the flexibility to spend on what actually matters to them,” Shubat explained. This philosophy is fueling the rapid adoption of Lifestyle Spending Accounts (LSAs). These employer-funded accounts provide employees with a flexible allowance to spend on a wide range of wellness, family, and personal development categories.
The momentum is undeniable. Espresa clients alone added nearly $250 million in new LSA funding in the past year, with the number of employees eligible for these accounts growing by almost 50%. The underlying logic is that a dollar spent on a benefit an employee truly wants—be it a gym membership, financial planning services, or childcare support—delivers a far greater return in engagement and loyalty than a dollar spent on a traditional, one-size-fits-all plan that goes unused.
A New Definition of 'Benefit'
This shift represents more than a cost-containment strategy; it signals an evolution in the very definition of a workplace benefit. The move is away from rigid, paternalistic packages and toward a 'choose your own adventure' model that empowers employees. By offering LSAs, companies like Nielsen are seeing a profound shift in engagement.
“During my 30+ year career in benefits, it seems we always had the same group of employees participating in our wellness programs,” noted Jackie Good, Global Wellbeing Manager at Nielsen. “By implementing Espresa’s LSA options, we drove significant results, increasing our employees' participation YOY and, most importantly, attracting and engaging a much more diverse group of employees.”
When given the choice, employees reveal a much broader and more personal set of needs. Espresa's data shows that alongside traditional fitness and wellness, employees are using their LSA funds for tax preparation, hobby classes, and financial planning—categories that support a holistic sense of well-being. The result is a powerful tool for retention. A remarkable 95% of organizations in the report cited improved employee retention after implementing LSAs, with a median improvement of nearly 20%. In a market where talent is everything, that is a metric no executive can afford to ignore.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →